Acuerdo Marco para el Suministro de Medicamentos sin competencia para los Hospitales del Servicio Cántabro de Salud (Principios activos Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetida hidrocloruro, Evolocumab, Inebilizumab, panitumumab)

Deadline:N/A

Tender information
A Coruña
Cantabria
Asturias
Pontevedra
Lugo
Ourense
Type
Contract award
Procedure
Negotiated without a call for competition
Ref. number
AM PN SCS/2026/80
Contract type
Framework agreement
Acuerdo Marco para el Suministro de Medicamentos sin competencia para los Hospitales del Servicio Cántabro de Salud (Principios activos Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetida hidrocloruro, Evolocumab, Inebilizumab, panitumumab)

Lote 1. Blincyto (Blinatumomab)

Lote 1. Blincyto (Blinatumomab)

Lote 3. Lumykras (Sotorasib)

Lote 3. Lumykras (Sotorasib)

Lote 4. Nplate (Romiplostim)

Lote 4. Nplate (Romiplostim)

Lote 5. Parsabiv (Etelcalcetida Hidrocloruro)

Lote 5. Parsabiv (Etelcalcetida Hidrocloruro)

Lote 7. Uplizna (Inebilizumab)

Lote 7. Uplizna (Inebilizumab)

Lote 8. Vectibix (Panitumumab)

Lote 8. Vectibix (Panitumumab)

Buyer
Servicio Cántabro de Salud
buyer-email@mail.com
organization number
Contract award
tenderer iconAMGEN S.A.tenderer status icon trophyAwarded

Documents

Document name
Upload date
File size
First document.pdf1 Jan 1970, 00:001 Bytes
Second document.pdf1 Jan 1970, 00:001 Bytes
Contract awarded
Important dates
24 Sept - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?